Claim Missing Document
Check
Articles

Found 16 Documents
Search

Genistein Increase Intracellular Distribution of the High Motility Group Box-1 through p38 Pathway in HeLa culture cells induced by Tumor Necrosis Factor-α Merlita Herbani; Aris Widodo; Hidayat Suyuti
Journal of Tropical Life Science Vol. 4 No. 2 (2014)
Publisher : Journal of Tropical Life Science

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Cervical cancer is one kind of many cancer that cause death to women around the world. Many studies had support the statement that inflammation has a strong linkage with cancer development. Several factors like proinflammatory factor can influence tumor cell microenvironment, and induce a faster proliferation. TNF-α is suspected can induce proliferation. While cancer itself can induce inflammation, which is marked by several marker. One of them is HMGB1, released from the cell as active secretory lysosomes or passive diffusion. Genistein has demonstrated growth inhibitory effects of various types of cancer cells. It inhibits tyrosine kinase pathway, which can be activated by TNF-α. One of those pathways that have the link with proliferation is p38. This study tries to reveal about inhibitory effect of genistein toward p38 pathway that had been activated by TNF-α. This research was conducted by exposing cultured HeLa cells with various doses of genistein for 90 minutes, and then exposed to TNF - α 10 ng / mL for 20 minutes. Observations were made with a confocal microscope, by staining the cells with pp38-TRITC and HMGB1 antibody. The intensity was measured and analyzed by Fluoview software. The results suggest that there be significant differences between pp38 intranuclear intensity and HMGB1 extranuclear intensity of each dose of genistein (p = 0.000, ANOVA). pp38 and HMGB1 intensity were increased along with increasing genistein dose, but at high dose there were noted decreasing of pp38 and HMGB1 intensity. At apoptotic dose, pp38 and HMGB1 intensity were increased markedly, showing the effect of apoptosis. In general, increasing doses of genistein increase intranuclear p38 activation and HMGB1 extranuclear translocation. So there were a strong linkage between p38 activation and HMGB1 translocation in this study.
Studi Docking Molekuler Penghambatan Reseptor Neprilysin Bunga Lawang (Illicium verum) sebagai Anti Hipertensi dan Prediksi Profil Farmakokinetikanya Andri Tilaqza; Merlita Herbani; Zaenab Aqilah
Jurnal Ilmiah Biosaintropis (Bioscience-Tropic) Vol 9 No 1 (2023): Agustus 2023
Publisher : Fakultas Matematika & Ilmu Pengetahuan Alam - Universitas Islam Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33474/e-jbst.v9i1.529

Abstract

Prosedur TEVAR pada Diseksi Aorta Klasik tipe B Kronis Herbani, Merlita; Kurnianingsih , Novi
Jurnal Klinik dan Riset Kesehatan Vol 3 No 2 (2024): Edisi Februari
Publisher : RSUD Dr. Saiful Anwar Province of East Java

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.11594/jk-risk.03.2.8

Abstract

Introduction : Type B aortic dissection still become health burden that can cost quality of life. In this case, TEVAR procedure still become treatment of choice if indicated. However, TEVAR in chronic type B aortic dissection still often questioned between advantage and complication. Case Illustration : A 42 year old man with complaints of chest pain, was diagnosed with Chronic Type B Aortic Dissection. The TEVAR procedure is performed on the patient, with clinical and radiological indications. A CT scan evaluation was performed 3 months later and found closure of the false lumen, and the left kidney received collateral vascularization with a reduction in size. Currently the patient does not complain of any symptoms. Discussion : The TEVAR procedure for chronic type B aortic dissection according to indications can increase the patient's life expectancy. Regular evaluation is still needed for early detection of complications and evaluation of the blood vessels around the stent-graft. Conclusion : The TEVAR procedure in patients with chronic type B aortic dissection can be considered to increase patient survival.
Prosedur TEVAR pada Diseksi Aorta Klasik tipe B Kronis Herbani, Merlita; Kurnianingsih , Novi
Jurnal Klinik dan Riset Kesehatan Vol 3 No 2 (2024): Edisi Februari
Publisher : RSUD Dr. Saiful Anwar Province of East Java

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.11594/jk-risk.03.2.8

Abstract

Introduction : Type B aortic dissection still become health burden that can cost quality of life. In this case, TEVAR procedure still become treatment of choice if indicated. However, TEVAR in chronic type B aortic dissection still often questioned between advantage and complication. Case Illustration : A 42 year old man with complaints of chest pain, was diagnosed with Chronic Type B Aortic Dissection. The TEVAR procedure is performed on the patient, with clinical and radiological indications. A CT scan evaluation was performed 3 months later and found closure of the false lumen, and the left kidney received collateral vascularization with a reduction in size. Currently the patient does not complain of any symptoms. Discussion : The TEVAR procedure for chronic type B aortic dissection according to indications can increase the patient's life expectancy. Regular evaluation is still needed for early detection of complications and evaluation of the blood vessels around the stent-graft. Conclusion : The TEVAR procedure in patients with chronic type B aortic dissection can be considered to increase patient survival.
Misdiagnosed acute coronary syndrome masking a giant mediastinal mass causing obstructive shock: A case report Herbani, Merlita; Satrijo, Budi
Heart Science Journal Vol. 7 No. 4 (2026): Navigating High-Risk Cardiovascular Subsets: Premature Disease, Plaque Complexi
Publisher : Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.hsj.2026.007.04.14

Abstract

Background: Mediastinal tumors with intracardiac extension are exceedingly rare. Nevertheless, when both occur simultaneously, the most severe consequence is obstructive shock from mechanical inflow tract occlusion. This case illustrates the therapeutic paradox between emergency hemodynamic surgical rescue and the perioperative bleeding risk of prior antithrombotic therapy. Case Presentations: We report a 50-year-old man who was initially misdiagnosed with non-ST-elevation acute coronary syndrome (NSTE-ACS) and then received dual antiplatelet therapy (DAPT) and anticoagulant from the previous hospital. He then developed superior vena cava (SVC) syndrome with progressive hypoxemia and obstructive shock, prompting referral to our tertiary hospital. Bedside echocardiography revealed a large mass in the right atrium that originated from the superior vena cava and intermittently occluded the tricuspid valve. A patent foramen ovale (PFO) with right-to-left shunting was also identified. The multidisciplinary Heart Team recommended emergency open heart surgery for tumour evacuation and PFO repair, despite the substantial bleeding risk. Subsequent histopathology revealed thymic lymphoepithelial carcinoma. The patient succumbed to hemorrhagic shock despite aggressive damage-control resuscitation. Conclusions: This case highlights the critical utility of early point-of-care echocardiography in differentiating structural, mechanical causes of obstructive shock from acute coronary syndrome. It further underscores the therapeutic paradox faced by multidisciplinary Heart Teams when mandatory, emergency surgical decompression carries an extreme risk of catastrophic hemorrhage due to recent aggressive antithrombotic therapy.
Predictors of major adverse cardiovascular events after percutaneous coronary intervention in premature coronary artery disease: An Indonesian single-centre cohort study Suryo Baskoro, Shalahuddin; Noverikhe, Nikhen; Herbani, Merlita; Filano, Marco; Veliawan, Zhafran; Yolanda, Anindia Reina; Wulandari, Ayu Paramitha; Rohman, Muhammad Saifur; Satrijo, Budi
Heart Science Journal Vol. 7 No. 4 (2026): Navigating High-Risk Cardiovascular Subsets: Premature Disease, Plaque Complexi
Publisher : Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.hsj.2026.007.04.8

Abstract

Background: Premature coronary artery disease (PCAD) is increasingly recognised in Asian percutaneous coronary intervention (PCI) practice, yet baseline predictors of major adverse cardiovascular events (MACE) after revascularisation remain poorly characterised.Objective: To identify independent baseline predictors of MACE after PCI in PCAD and determine whether a stricter "Asia Pacific" age band discriminates risk within the premature range.Methods:  Retrospective cohort study at a tertiary PCI centre in Malang, Indonesia (January 2022–March 2025; follow-up censored 1 May 2026). Patients meeting 2019 ACC/AHA PCAD criteria (men <55 years or women <65 years) with confirmed obstructive coronary artery disease (CAD) treated by PCI were enrolled. The primary outcome was composite MACE (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, heart-failure hospitalisation, or unplanned revascularisation), assessed by cause-specific Cox proportional-hazards regression.Result: Among 318 patients who completed follow-up (median age 50 years; 31.4% women; median follow-up 930.5 days), 41 MACE events occurred (12.9%). MACE incidence was similar between Asia Pacific PCAD (n=159; 11.3%) and Older PCAD (n=159; 14.5%; 3-year cumulative incidence 12.0% vs 16.9%; log-rank p=0.308). Reduced left ventricular ejection fraction (LVEF <40%) and dyslipidaemia were independent baseline predictors (LVEF <40%: adjusted HR 1.79, 95% CI 1.09–2.95; dyslipidaemia: adjusted HR 3.84, 95% CI 2.09–7.07; C=0.717, bootstrap-corrected C=0.715 (1000 resamples; optimism +0.002)).Conclusion: Reduced LVEF and dyslipidaemia were the principal baseline predictors of MACE in this Indonesian single-centre PCAD post-PCI cohort; age stratification within the premature range did not discriminate risk. Results should be interpreted in the context of 29.3% loss to follow-up and single-centre design.